Treatment of head and neck cancer with intra-arterial cytotoxic drugs and radiotherapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007269:Injections, Intra-Arterial; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D013852:Thiotepa / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014747:Vinblastine; D013852:Thiotepa; D008727:Methotrexate